Skip to main content
Clinical Trials/ISRCTN29686154
ISRCTN29686154
Completed
Not Applicable

Prevention of catheter-related deep vein thrombosis with nadroparin in hemato-oncology patients treated with high dose chemotherapy

Academic Medical Center (AMC) (The Netherlands)0 sites100 target enrollmentJune 9, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemato-oncology patients with deep vein thrombosis
Sponsor
Academic Medical Center (AMC) (The Netherlands)
Enrollment
100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Academic Medical Center (AMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Central venous catheter
  • 2\. Indication for high dose chemotherapy (acute myeloid leukaemia \[AML], acute lymphoblastic leukaemia \[ALL], myelodysplasia\-refractory anemia with excess of blasts in transformation \[MDS\-RAEB], multiple mye!oma \[MM])
  • 3\. Informed consent

Exclusion Criteria

  • 1\. Current anticoagulant therapy
  • 2\. Allergy for contrastmedia
  • 3\.Promyelocytic leukemia (AML\-M3\)
  • 4\. Bleeding tendency
  • 5\. Renal failure

Outcomes

Primary Outcomes

Not specified

Similar Trials